Company Name: |
Lynnchem
|
Tel: |
86-(0)29-85992781 17792393971 |
Email: |
info@lynnchem.com |
Products Intro: |
Product Name:Daclatasvir Impurity E CAS:1009113-58-9 Purity:95% Package:5mg;25mg
|
Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
Tel: |
15374522761 |
Email: |
3003392093@qq.com |
Products Intro: |
Product Name:Daclatasvir Impurity 39 CAS:1009113-58-9 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
Novachemistry
|
Tel: |
44-20819178-90 02081917890 |
Email: |
info@novachemistry.com |
Products Intro: |
Product Name:Daclatasvir Impurity E CAS:1009113-58-9 Purity:95% Package:5mg;25mg
|
Company Name: |
Cato Research Chemicals Inc.
|
Tel: |
020-81215950 4000-868-328 |
Email: |
customer@uwalab.com |
Products Intro: |
Product Name:Daclatasvir Impurity 4 CAS:1009113-58-9 Purity:95%(HPLC) Package:10mg;25mg;50mg;100mg
|
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Email: |
marketing1@energy-chemical.com |
Products Intro: |
Product Name:Daclatasvir Diethyl Ester CAS:1009113-58-9 Purity:NULL Package:100mg;10mg;5mg Remarks:NULL
|
|
| Daclatasvir Impurity E Basic information |
Product Name: | Daclatasvir Impurity E | Synonyms: | Daclatasvir Impurity E;Daclatasvir Di-Ethyl Ester;Daclatasvir impurity 10/Daclatasvir Diethyl Ester/N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxoethyl]]]biscarbamic Acid C,C'-Diethyl Ester;Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxoethyl]]]bis-, C,C'-diethyl ester | CAS: | 1009113-58-9 | MF: | C42H54N8O6 | MW: | 766.93 | EINECS: | | Product Categories: | | Mol File: | 1009113-58-9.mol | ![Daclatasvir Impurity E Structure](CAS/20180808/GIF/1009113-58-9.gif) |
| Daclatasvir Impurity E Chemical Properties |
Boiling point | 1075.1±65.0 °C(Predicted) | density | 1.228±0.06 g/cm3(Predicted) | pka | 11.17±0.46(Predicted) |
| Daclatasvir Impurity E Usage And Synthesis |
Uses | Daclatasvir Diethyl Ester is an impurity of Daclatasvir (D101500); a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). |
| Daclatasvir Impurity E Preparation Products And Raw materials |
|